Session Details
[27-64-pm1]Drug design
Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Room 64 (Collaboration Commons, RINPUKAN [1F]) (1)
Discusser: Kanoh Naoki, Sugita Kazuyuki
[27-64-pm1-01S]Synthesis of middle-molecules based on abietic acid using a natural product reconstruction strategy
○Fumiaki Kobayashi1, Takehiro Nishimura1, Haruhisa Kikuchi1 (1. Fac. Pharm., Keio Univ.)
[27-64-pm1-02S]Investigation of Crystallization and Water-Soluble Salt Formation of RXR Agonist NEt-3IB
○Yuta Hino1, Yu Takaki2, Yuta Takamura2, Kazumasa Horigane3, Kakuta Hiroki2 (1. Okayama University, School of Pharmaceutical Sciences, 2. Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 3. Okayama University, Advanced Science Research Center)
[27-64-pm1-03S]Reducing off-target effects of siRNA with base-modified nucleosides②
○Makoto Yahata1, Yuhei Nogi2, Taketo Inoue2, Ayano Ebisui1, Jun Tsukimoto2, Noriko Saito-Tarashima2, Noriaki Minakawa2 (1. Fac. Pharm. Sci., Tokushima Univ., 2. Grad. Sch. Pharm. Sci., Tokushima Univ.)
[27-64-pm1-04S]Discovery of bromodomain-targeting anticancer drugs via AI drug discovery
○Natsumi Noda1, Arisa Chiba1, Kayo Nakamura1, Hidetsugu Tabata2, Tetsuta Oshitari2, Chisato Kanai3, Atsushi Yoshimori4, Tomohiko Tasaka5, Hideaki Natsugari5, Ryoko Takasawa1, Hideyo Takahashi1 (1. Faculty of Pharm. Sci., Tokyo Univ. of Science, 2. Faculty of Pharm. Sci., Teikyo Univ., 3. INTAGE Healthcare, 4. Institute for Theoretical Medicine, 5. AFFINITY SCIENCE CORPORATION)
[27-64-pm1-05S]Synthesis of Novel Copper Complexes for the Treatment of Menkes Disease
○Ayame Shoji1, Kayo Nakamura1, Yoshiaki Yamagishi2, Toshiyuki Kudo2, Hidetsugu Tabata3, Tetsuta Oshitari3, Hideaki Natsugari4, Tomoya Fujie1, Kiyomi Ito2, Hideyo Takahashi1 (1. Pharm. Sci., Tokyo Univ. Sci., 2. Pharm. Sci., Musashino Univ., 3. Pharm. Sci., Teikyo Univ., 4. Pharm. Sci., Niigata Univ. Pharm. Med. Life Sci.)
[27-64-pm1-06S]Multi-objective molecule generation integrating Boltz-2 and pharmacokinetic prediction
○Tatsuya Yoshizawa1,2, Tomohiro Sato2, Masateru Ohta3, Teruki Honma2, Kei Terayama1,4,5 (1. Grad. Sch. Med. Life Sci., Yokohama City Univ., 2. RIKEN IMS, 3. LINC, 4. Dept. of Life Science and Technology, Science Tokyo, 5. RIKEN AIP)
[27-64-pm1-07S]Synthesis and inhibitory activity on kynurenine production by flavonoids
○Kazuki Yamanoi1, Daisuke Tsuji1, Reiko Akagi1, Yui Kajiura1, Yuto Momose2, Makoto Inai3, Toshiyuki Kan3, Osamu Ohno2, Kenji Matsuno1 (1. Faculty of Pharmacy, Yasuda Women's University, 2. School of Advanced Engineering, Kogakuin University, 3. School of Pharmaceutical Sciences, University of Shizuoka)
[27-64-pm1-08S]Development of a data-driven screening method based on high-efficiency Bayesian Optimization
○Daiki Ishimoto1, Ryo Tachibana1, Yasuteru Urano1,2 (1. Grad. Sch. Pharm. Sci., Univ. Tokyo, 2. Grad. Sch. Med., Univ. Tokyo)
[27-64-pm1-09S]Study on the Action Mechanism of Vitamin D Derivative Dcha-20 as Rodenticide
○Miyuna Yoshihara1, Chiharu Ogura1, Kana Okamura1, Misaki Fukamatsu2, Ryo Kamata2, Kazuki Takeda2, Satoru Nagaoka3, Hiroyuki Kagechika4, Aya Tanatani1 (1. Grad. Sch. Adv. Sci., Ochanomizu Univ., 2. Grad. Sch. Vet. Med., Kitasato Univ., 3. Daimaru Compound Chemical CO., LTD., 4. Lab. Biomater. Bioeng., Inst. Integ. Res., Inst. Science Tokyo.)